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Thrombus formation on a disrupted atherosclerotic plaque is a key event that leads to atherothrombosis. Because thrombus
is induced by chemical or physical injury of normal arteries in most animal models of thrombosis, the mechanisms of
thrombogenesis and thrombus growth in atherosclerotic vessels should be investigated in diseased arteries of appropriate
models. Pathological ﬁndings of human atherothrombosis suggest that tissue factor, an initiator of the coagulation cascade,
signiﬁcantly aﬀects enhanced platelet aggregation and ﬁbrin formation after plaque disruption. We established a rabbit model
of atherothrombosis based on human pathology in which diﬀerences in thrombus formation between normal and atherosclerotic
arteries, factors contributing to thrombus growth, and mechanisms of plaque erosion can be investigated. Emerging transgenic
and stem cell technologies should also provide an invaluable rabbit experimental model in the near future.
1.Introduction
Acutecardiovasculareventsusuallyinvolvethrombusforma-
tion at sites of disrupted atherosclerotic plaque, which is cur-
rently referred to as atherothrombosis. Although thrombosis
is a major complication of atherosclerosis, it does not always
result in complete thrombotic occlusion with subsequent
acute symptomatic events [1]. Therefore, thrombus growth
is critical to the onset of clinical events. Thrombus formation
is probably regulated by the thrombogenicity of exposed
plaque constituents, local hemorheology, systemic throm-
bogenicity, and ﬁbrinolytic activity. In fact, the molecular
mechanisms of thrombus formation have been identiﬁed in
mice due to advances in gene targeting technology. However,
thrombus is induced by chemically or physically damaging
normal arteries in most of these methods. Therefore, little
is known about the mechanisms involved in thrombogenesis
and thrombus growth in atherosclerotic vessels.
Tissue factor (TF) is a membrane-bound glycoprotein
that is expressed or exposed at sites of vascular injury and
is essential for hemostasis. As an initiator of the coagulation
system, TF acts as a cofactor for circulating factor VIIa, and
it starts a series of proteolytic reactions that culminate in
the production of the enzyme thrombin, which is the ﬁnal
eﬀecter of the coagulation system. TF is distributed in the
adventitia and variably in the media of normal vessels [2].
Active TF has been pathologically detected in atherosclerotic
lesions and in platelet-ﬁbrin thrombus formed at disrupted
sites. Atherosclerotic lesions are indispensable for studying
atherothrombosis. The lipoprotein proﬁles of rabbits are
similar to those of humans but not mice [3], and rabbits
on a hyperlipidemic diet are susceptible to atherogenesis.
We thus established a rabbit model of atherothrombosis
based on human pathology. This paper focuses on human
atherothrombosis,arabbitmodel,anditspathophysiological
signiﬁcance.
2.HumanPathology
2.1.PathologyofCoronaryAtherothrombosis. Arterialthrom-
bi were traditionally considered to mainly comprise aggre-
gated platelets because of rapid ﬂow, and the development
of platelet-rich thrombi has been regarded as a trigger of
atherothrombosis. However, recent evidence indicates that
thrombi on disrupted plaques are composed of aggregated
platelets and ﬁbrin, erythrocytes, and white blood cells,
which are immunopositive for glycoprotein (GP) IIb/IIIa
(a platelet integrin), ﬁbrin, glycophorin A (a membrane2 Journal of Biomedicine and Biotechnology
protein expressed on erythrocytes), von Willebrand factor
(VWF, a blood adhesion molecule), and CD16 (a marker
of neutrophils) [4–6]. GP IIb/IIIa colocalized with VWF,
and TF was closely associated with ﬁbrin [5]( Figure 1).
These ﬁndings suggest that VWF and/or TF contribute to
thrombus growth and to obstructive thrombus formation
on atherosclerotic lesions, and that the enhanced platelet
aggregation and ﬁbrin formation indicate excess thrombin
generation mediated by TF.
TF and its procoagulant activities are overexpressed in
human atherosclerotic plaques [7, 8], and macrophages
and smooth muscle cells (SMCs) in the intima express TF.
The activity of TF is more prominent in fatty streaks and
atheromatous plaques than in diﬀuse intimal thickening in
the aorta [8]. Thus, atherosclerotic plaque has the potential
to initiate the coagulation cascade after plaque disruption,
and TF in such plaque is thought to play an important role
in thrombus formation after plaque disruption.
The two major morphological features of plaque dis-
ruption are rupture and erosion (Figure 2). Plaque rupture
is caused by disruption of the ﬁbrous cap, which allows
contact between blood and a thrombogenic necrotized core,
resulting in thrombus formation. Rupture probably occurs
in plaques with a large necrotized lipid core and ﬁbrous caps
thatareheavilyinﬁltratedbymacrophages,lymphocytes,and
occasional smooth muscle cells (SMC)s [9]. Plaque disrup-
tion and thrombosis in the absence of ﬁbrous cap thinning
characterizes plaque erosion. Angiographically, an artery
with eroded plaque is less narrowed and the luminal surface
is irregular. The morphological characteristics include an
abundance of SMCs and proteoglycan matrix, especially
versican and hyaluronan, and no necrotic core. Relatively
few macrophages and T cells are features of plaque erosion
compared with rupture [9]. The proportions of ﬁbrin
and platelets diﬀer in coronary thrombi on ruptured and
eroded plaques. Fibrin- and platelet-rich thrombi develop
o nr u p t u r e da n do ne r o d e dp l a q u e s ,r e s p e c t i v e l y ,a n db o t h
TF and C-reactive protein are more abundant in ruptured
and than eroded plaques [4]. These distinct morphological
features suggest that diﬀerent mechanisms are involved in
plaque rupture and erosion.
On the other hand, atherosclerotic plaque disruption
does not always result in complete thrombotic occlusion
with subsequent acute symptomatic events. Clinical studies
using angiography and intravascular ultrasound have found
that the rupture of several plaques is a frequent com-
plication among patients with coronary atherothrombosis
[10]. Disrupted plaques at various stages of healing are
occasionallyfoundinautopsycaseswithorwithoutcoronary
atherothrombosis [11]. To evaluate the incidence and mor-
phological characteristics of thrombi and plaque disruption
in patients with noncardiac death, Sato et al. [12] examined
102 and 19 hearts from autopsy cases with noncardiac death
and from those who died of acute myocardial infarction
(AMI). Surprisingly, they found coronary thrombi in 16%
of the cases with noncardiac death, and most of them
had developed on eroded plaque. However, the thrombi
were too small to aﬀect the coronary lumen (Table 1). The
lipid cores were smaller, the ﬁbrous caps were thicker, and
Table 1: Incidence of thrombosis in NCD and AMI.
NCD (n = 102) AMI (n = 19) P value
Fresh thrombus (n) 10 (10%) 14 (74%) <.001
(i) Erosion 7 (7%) 4 (21%) .07
(ii) Rupture 3 (3%) 10 (53%) <.001
Old thrombus 6 (6%) 5 (26%) <.05
NCD:noncardiacdisease;AMI:acutemyocardialinfarction(fromSatoetal.
[12] with permission).
luminal narrowing was more modest in disrupted plaques
from cases with noncardiac death than with AMI. These
ﬁndings suggested that the onset of acute coronary events
represents the tip of the atherothrombosis iceberg and that
regional factors inﬂuence coronary thrombus growth after
plaque disruption. Thrombus growth is critical to the onset
of clinical events because plaque disruption does not always
result in complete thrombotic occlusion with subsequent
acute symptomatic events.
2.2. Mechanisms of Plaque Rupture Determined from Human
Pathology. Accumulating evidence supports the notion that
inﬂammation plays a key role in thinning and disruption of
the ﬁbrous cap, which results in plaque rupture. The numer-
ous inﬂammatory cells in rupture-prone atherosclerotic
plaques can produce enzymes that degrade the extracellular
matrix of the ﬁbrous cap. Macrophages in human atheromas
overexpress interstitial collagenases, gelatinases, and elas-
tolytic enzymes. Activated T lymphocytes and macrophages
can secrete interferon γ (INF-γ), which inhibits collagen
synthesis and induces the apoptotic death of SMC [13].
Moreover, INF-γ can induce interleukin- (IL-) 18, which
accelerates inﬂammation. Interleukin-18 colocalizes with
INF-γ in macrophages located at the shoulder region, and it
is associated with coronary thrombus formation in patients
with ischemic heart disease [14]. Interestingly, the important
anti-inﬂammatory cytokine IL-10 is also upregulated in
macrophages in atherosclerotic lesions from patients with
unstable compared with stable angina [15]. The heterogene-
ity of macrophages in atherosclerotic plaque could explain
these paradoxical ﬁndings [16]. This evidence indicates that
an imbalance of the inﬂammatory pathway participates in
plaque destabilization that triggers thrombosis in ﬁbrous cap
rupture.
Intraplaque hemorrhage might also trigger plaque rup-
ture. The frequency of previous hemorrhages is greater
in coronary atherosclerotic lesions with late necrosis and
with a thin ﬁbrous cap than in those with early necrosis
or intimal thickening [17]. Intraplaque hemorrhage and
iron deposition are more prominent in coronary culprit
lesions obtained by directional coronary atherectomy from
patients with unstable than with stable angina pectoris.
The iron deposition correlates with oxidized low-density
lipoproteinandthioredoxin,anantioxidantprotein,andalso
associates with thrombus formation [18]. The pathological
ﬁndingsimplyrelationshipsamongintraplaquehemorrhage,
oxidative stress, and plaque instability. However, direct evi-
dence linking intraplaque hemorrhage and plaque instability
remains elusive.Journal of Biomedicine and Biotechnology 3
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Figure 1: Immunoﬂuorescence images of fresh coronary thrombi from patients with acute myocardial infarction. Images of thrombi stained
with ﬂuorescein isothiocyanate-labeled glycoprotein (GP) IIb/IIIa, von Willebrand factor (VWF), or tissue factor (TF) (green), Cy3-labeled
ﬁbrin or VWF (red), and merged images. Areas with colocalized factors are stained yellow (from Yamashita et al. [5] with permission).
2.3. Mechanism of Plaque Erosion is Unknown. Some authors
have postulated that erosion results from vasospasm, but
the mechanisms of plaque erosion remain poorly under-
stood. About 80% of the thrombi associated with plaque
erosions are nonocclusive even in sudden coronary death
[9]. Among patients who suddenly die, platelet-rich emboli
are found in 74% and 40% of those with plaque erosion
and plaque rupture, respectively. Because activated platelets
release vasoconstrictive agents such as 5-hydroxytryptamine
(5-HT, serotonin) and thromboxane A2, these emboli might4 Journal of Biomedicine and Biotechnology
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Figure 2: Coronary plaque rupture and erosion with thrombi. Large necrotic core and disrupted thin ﬁbrous cap is accompanied by
thrombus formation in ruptured plaque. Eroded plaque has superﬁcial injury of SMC-rich atherosclerotic lesion with thrombus formation.
Both thrombi comprise platelets and ﬁbrin. HE, hematoxylin eosin stain (from Sato et al. [4] with permission).
increase peripheral resistance leading to altered coronary
blood ﬂow. Furthermore, 5-HT can induce vasoconstriction
and reduce coronary blood ﬂow in human atherosclerotic
vessels, but not in normal arteries [19]. Such vasoconstric-
tion might play an important role in the pathogenesis of
plaque erosion. On the other hand, Durand et al. [20]
reported that the induction of endothelial apoptosis in vivo
leads to both endothelial denudation and vessel throm-
bosis in rabbit femoral arteries. However, the endogenous
triggers of endothelial apoptosis were not determined and
the mechanisms of superﬁcial erosive damage to SMC-
rich plaque remain unknown. However, understanding of
these processes can progress using SMC-rich atherosclerotic
vessels in rabbits as described below.
3. Current Arterial Thrombosis Models
Most established models of thrombosis have used either
chemical damage with ferric chloride or rose bengal with
focal irradiation. Kurz et al. [21] originally demonstrated
that the direct application of ferric chloride solution to
the adventitial surface of an artery rapidly induces the
formation of a platelet-rich thrombus that typically pro-
gresses to complete vascular occlusion. This type of damage
produces transmural cell necrosis and disrupts the integrity
of the vascular endothelium. However, the mechanism of
thrombosis triggered by ferric chloride has not been deﬁned.
A small piece of ﬁlter paper is saturated with 10%–50%
ferric chloride and applied to an artery, where it can be
visualized by stereoscopic microscopy. The photochemical
model involves the intravenous administration of photo-
reactive rose bengal to an exposed arterial segment that is
then illuminated with green light (540nm) delivered from a
xenon lamp equipped with a heat-absorbing ﬁlter [22]. Rose
bengal accumulates in the lipid bilayer of endothelial and
othertypesofcells[23].Greenlighttriggersaphotochemical
reaction in rose bengal that produces singlet oxygen and
promotes the formation of other reactive oxygen species that
damage the endothelium and initiate thrombus formation.
The reproducibility of occlusive thrombus formation hasJournal of Biomedicine and Biotechnology 5
led to these models becoming the established standard
for thrombus model. However, degenerative changes occur
in the walls of arteries that have been exposed to ferric
chloride and blood content is also altered. The color and
shape of these vessels change, the “thrombus” lacks cellular
and ﬁbrillar structures, and they microscopically appear
rather homogeneous (Figure 3). These ﬁndings suggest that
denatured materials are a direct consequence of a chemical
reaction rather than of sequential biological reactions.
Illumination can potentiate platelet function [24], and such
thrombus is composed of aggregated platelets [25]. These
considerably diﬀer from physiological thrombus formation
after plaque disruption. Moreover, many methods involve
triggering thrombus formation in normal arteries, which
imposes a critical limitation because atherothrombosis in
humans always occurs within atherosclerotic arteries. To
understand the mechanisms of atherothrombosis requires
investigation of a more relevant thrombosis model that
comprises diseased arteries.
4. Rabbit Model of Atherothrombosis
Pathological ﬁndings from humans indicate that TF expres-
sion in atherosclerotic plaque plays an important role in
thrombus formation after plaque disruption. To understand
the role of TF in plaques on thrombus formation and more
universally, the mechanisms of atherothrombosis, we used a
balloon catheter to induce TF expressing neointima in rabbit
femoral artery and to induce thrombus formation on the
neointima [26–28].
4.1. Induction of Macrophage- or SMC-Rich Atherosclerotic
Lesions by Balloon Injury with or without a High-Cholesterol
Diet. Rabbits weighting 2.5–3.0kg were fed with a con-
ventional or a 0.5% cholesterol diet for one week before
and three weeks after balloon injury to induce SMC- or
macrophage-rich neointima in femoral arteries, respectively.
The rabbits were anesthetized with pentobarbital (25mg/kg,
i.v.) and then an angioplasty balloon catheter (diameter,
2.5mm; length, 10mm) was inserted into the femoral artery
under ﬂuoroscopic guidance. The catheter was inﬂated to
1.5atm and retracted by 50mm three times to denude the
endothelium. This strategy causes SMC- or macrophage-
rich neointima with increased TF activity to develop several
weeks later. Figure 4 shows that neointima developed in
femoral arteries three weeks after balloon injury in rabbits
fed with conventional or 0.5% cholesterol diets. The neoin-
timal area was larger in rabbits fed with the cholesterol, than
with the conventional diet. Immunohistochemical staining
revealed that neointima induced under conventional or
c h o l e s t e r o ld i e ti sS M Co rm a c r o p h a g er i c h ,r e s p e c t i v e l y ,
and that TF was localized in both neointima and adventitia.
The activity of TF was assessed as rabbit plasma clotting
time increased more in the SMC- and macrophage-rich
neointima/media than in normal intima/media [27, 28]. The
increased neointimal TF expression and activity simulated
the situation in human atherosclerotic plaques [7, 8], and
the SMC- or macrophage-rich neointima mimics human
200μm
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Figure 3: Histological images of carotid artery from rat ferric
chloride model. (a) Longitudinal section of rat carotid artery 20
minutes after initiation of 20% ferric chloride injury. Arterial wall
and blood show marked degenerative or denaturation changes at
site of injury (arrows), wall constriction, and brown color at blood-
vessel interface. Hematoxylin eosin stain. (b) Higher magniﬁcation
of attached thrombus (∗) shows absence of cellular and ﬁbrillar
structuresandratherhomogeneousappearance.Hematoxylineosin
stain.
ﬁbrocellular and lipid-rich types of plaque, respectively [4,
29, 30].
However, the remodeling response after balloon injury
signiﬁcantly diﬀers between conventional and cholesterol
diets. The numbers of inﬂammatory cells, especially
macrophages, as well as microvessels and matrix metallopro-
teinase expression increased, and matrix density decreased
in the damaged arteries of rabbits fed with a cholesterol
diet, resulting in extensive arterial remodeling [31]. These
ﬁndings indicate that hyperlipidemia directly contributes to
arterial remodeling via inﬂammatory responses after arterial
injury.
4.2. Diﬀerent Mechanism of Thrombus Formation in
Atherosclerotic or Normal Artery. The arteries were further
damaged using a balloon catheter at three weeks after the
ﬁrst balloon injury to induce thrombus formation on the6 Journal of Biomedicine and Biotechnology
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Figure 4: Angiographic and histological images of rabbit femoral arteries. (a) Representative angiographic and histological image 3 weeks
after the balloon injury of left femoral artery. Injured femoral artery shows luminal narrowing and neointimal formation (N). Hematoxylin
eosin/Victria blue stain (from Yamashita et al. [27] with permission). (b) Representative immunohistochemical microphotographs of
normal and balloon-injured femoral arteries at 3 weeks after injury under conventional or 0.5% cholesterol diet. Tissue factor (TF) is
expressedinneointimalsmoothmuscle cells(SMCs),macrophages, andadventitia. I,intima;M,media;Ad,adventitia. HE/VB,hematoxylin
eosin/victoria blue stain.
neointima. A 2F balloon catheter (Baxter Healthcare) was
inserted via the anterior tibial artery into the femoral artery,
inﬂatedto1.4atm,andretractedthreetimes.Fifteenminutes
later, SMC- and macrophage-rich neointima produced large
thrombi composed of platelets and ﬁbrin, whereas small
platelet thrombi developed on the normal intima of rabbits
fed with both conventional and cholesterol diets (Figure 5)
[28]. Thrombus formation was assessed as cross-sectional
size under a microscope, areas that were immunopositive
for GPIIb/IIIa and ﬁbrin, or by blood ﬂowmeter
[27, 28].
Recombinant tissue factor pathway inhibitor and arga-
troban, a thrombin inhibitor, signiﬁcantly reduced platelet
aggregation, ﬁbrin formation, and thrombus formation on
both SMC- and macrophage-rich neointima, but not on
normal intima. These results suggested that the mechanism
of thrombus formation on normal and diseased arteries is
independent and dependent, respectively, on thrombin [28].
Thrombin is a multifunctional enzyme that is generated on
activated platelets by prothrombinase complexes comprising
activated factor X (FXa) and factor V. Thrombin promotes
the coagulation cascade, activates platelets, and inhibits pro-
teolysis [32]. Our ﬁndings indicate that thrombin generation
mediated by intimal TF contributes to the formation of large
thrombus in atherosclerotic vessels via enhanced platelet
aggregation and ﬁbrin formation. In addition, thrombus
formation on macrophage-rich neointima was sensitive to
inhibitors of TF-activated factor VII (FVIIa), FXa, and
thrombin. These results support the notion that thrombus
formation in this model is initiated by activation of the TF-
FVIIa pathway [33].
4.3. Other Atherothrombosis Models. Apolipoprotein E
(apoE) is a class of apolipoprotein that is essential for
the normal catabolism of triglyceride-rich lipoprotein const-
ituents. Apo E knockout mice develop hypercholesterolemia
and atherosclerotic lesions throughout the vasculature
with a predilection for bifurcation sites [34]. Eitzman et
al. [35] demonstrated that acute hyperlipidemia enhances
platelet activation and photochemically induced thrombus
formation on carotid atherosclerotic lesions of 30-week-old
apoE−/− mice. They also found shortened occlusion times in
30- versus 6-week-old mice, indicating that thrombogenicity
is increased in carotid plaque. Although the mechanism of
the enhanced thrombogenicity is unclear, this model is more
reﬂectiveofatherothrombosisthanphotochemicallyinduced
thrombosis in normal animal arteries. Intravital microscopy
has recently allowed real-time imaging of thrombus growth
and dissolution. Kuijpers et al. [36] generated a model of
thrombus formation evoked by plaque rupture in the carotid
arteries of apoE−/− mice fed with a western-type diet for 18–
20 weeks. Localized rupture at carotid plaque was induced
by ultrasound, and thrombus formation was visualized by
two-photon laser scanning microscopy. Such plaque damage
resulted in endothelial denudation, collagen exposure, and
mural thrombus formation, which relied on both platelet
activation and thrombin generation. This model might
prove useful for understanding the molecular mechanisms
of dynamic thrombus formation on atherosclerotic lesions.
Constantinides and Chakravarti introduced a rab-
bit model of atherothrombosis over 30 years ago [37].
Atherosclerotic lesions were induced in the aorta by a choles-
terol diet for 2–8 months with or without balloon injury, and8 Journal of Biomedicine and Biotechnology
injected Russell’s viper venom and histamine induced the
initiationofthrombusontheatheroscleroticlesions.Therate
ofplaquedisruptionwiththrombusformationwasoriginally
30% (cholesterol diet) and up to 70% (cholesterol diet plus
initial balloon injury) [38]. Large thrombus in the aorta
is useful for investigations using modalities such as mag-
netic resonance imaging and positron emission tomography
[39, 40].
5. Applications for SMC-Rich Atherosclerotic
Lesion on Thrombosis
Intima that is rich in SMCs and extracellular matrix is a basic
morphological feature of atherosclerotic lesions [9]. Coro-
nary arteries with SMC-rich intima are susceptible to vaso-
constriction or vasospasm induced by some thrombogenic
agents [41]. Pathological studies have demonstrated that the
coronary arteries of patients with coronary vasospasm have
SMC-rich intima [29] and that the intima of eroded plaques
contains signiﬁcantly more SMCs than that of stable or
ruptured plaques [30, 42]. The clinicopathological evidence
suggests a relationship between SMC-rich atherosclerotic
lesions and thrombogenic vasoconstriction and/or plaque
erosion.
5.1. Mechanisms of Plaque Erosion Determined in a Rabbit
Model. Unlike those of plaque rupture, the mechanisms of
plaque erosion remain obscure. Endothelial cells preferen-
tially undergo apoptosis at areas downstream of atheroscle-
rotic plaques, where blood ﬂow is disrupted and shear
stress is lower than at upstream areas [43]. Experimental
aortic stenosis can induce acute endothelial changes or
damage the normal aorta [44]. Therefore, hemodynamic
force, particularly disturbed blood ﬂow induced by stenosis
or vasoconstriction, could be a crucial factor in generating
surface vascular damage and thrombosis. In fact, blood ﬂow
disturbed by acute vascular narrowing induced superﬁcial
erosive injury to SMC-rich neointima at poststenotic regions
in rabbit femoral arteries. The blood ﬂow of the femoral
arteries was reduced to 75% with a vascular occluder.
The vascular narrowing induced a disturbed blood ﬂow at
poststenotic portion. Figure 6(a) shows microscope images
of a longitudinal section of neointima from the poststenotic
region at 15min after vascular narrowing. The endothelial
cells and SMCs at this region were broadly detached and
associated with platelet adhesion to the subendothelium
(Figures 6(a) and 6(b)). The superﬁcial erosive injury also
induced the apoptosis of endothelial cells and superﬁcial
SMCs within 15 minutes [45]. The neointima were com-
pletely lined by endothelial cells in the absence of vascular
narrowing, and there were no apoptotic cells in the intima.
Thus, disturbed blood ﬂow can induce superﬁcial erosive
injury to SMC-rich plaque and thrombus formation at the
poststenotic region. Computational ﬂuid simulation analysis
has indicated that oscillatory shear stress contributes to the
progress of erosive damage to the neointima [45]. Although
direct clinical evidence has not yet supported the notion that
coronary artery vasospasm plays a role in plaque erosion,
thesuperﬁcialerosiveinjuryofSMC-richneointimainduced
by disturbed blood ﬂow is similar to that of human plaque
erosion [4, 9]. In addition, platelets and blood coagulation
are activated in the coronary circulation after vasospastic
angina [46]. Therefore, these evidences together suggest that
acute-onset disturbed blood ﬂow caused by vasoconstriction
could trigger plaque erosion. Hemodynamic factors could
thus play important roles in the process of plaque erosion.
5.2. SMC-Rich Atherosclerotic Lesions on Thrombogenic Vaso-
constriction. Coronary artery contraction and spasm at sites
of atherosclerotic lesions have been studied in detail [47],
whereas relatively little is understood about the thrombus-
mediated constriction of diseased arteries. Plaque disruption
activates platelets that release many vasoactive substances
into the circulation. Rabbit femoral arteries with SMC-rich
atheroscleroticlesionsdeveloped ahypercontractileresponse
to 5-HT via 5-HT2A receptors, but not to any of adenosine
diphosphate, adenosine triphosphate, or thrombin. Notably,
5-HT caused the SMC-rich atherosclerotic lesion itself to
contraction. Moreover, the hypervasoconstriction of SMC-
rich atherosclerotic vessels alters blood ﬂow during throm-
bogenesis and aﬀects the formation of occlusive thrombus
in rabbits [48, 49]. The results indicate that thrombogenic
vasoconstriction induces luminal stenosis with reduced
blood ﬂow in culprit vessels and promotes further thrombus
growth.
6. Applications for Thrombus Growth Study
As described above, plaque disruption does not always result
in the complete thrombotic occlusion and thrombus growth
that are critical to the onset of clinical events. Thrombus
formation is probably regulated by vascular wall thrombo-
genicity, local blood ﬂow, and blood content. However, their
contribution to thrombus growth has not yet been deﬁned.
6.1. Role of Coagulation Factors on Thrombus Growth.
The most fundamental diﬀerence between normal and
atherosclerotic arteries is that active TF is abundant in
atherosclerotic lesions [7, 8]. Therefore, vascular wall TF
might contribute to thrombus formation/growth on such
lesions. However, recent studies have detected low levels of
TF in the blood that are nevertheless suﬃcient to support
clot formation in vitro. Plasma TF levels are elevated in
patients with unstable angina and AMI, and they correlate
with adverse outcomes [50]. Therefore, whether or not
TF derived from the vascular wall and/or blood supports
thrombuspropagationremainscontroversial.Hematopoietic
cell-derived, TF-positive microparticles contribute to laser
injury-induced thrombosis in the microvasculature of the
mouse cremaster muscle [51]. In contrast, TF derived from
hematopoietic cells does not contribute to photochemically-
induced thrombosis in the mouse carotid artery [52]. The
atheroscleroticlesionsinrabbitfemoralarteriesexpressedTF
and increased procoagulant activity compared with normal
femoral arteries. Thrombin-dependent large platelet-ﬁbrin
thrombi were induced in the neointima damaged by balloonJournal of Biomedicine and Biotechnology 9
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Figure 5: Light and immunoﬂuorescence microphotographs of thrombus on rabbit femoral arteries. Representative light and
immunoﬂuorescence microphotographs of thrombi that developed in normal femoral artery 15 minutes after balloon injury and in
atherosclerotic neointima from rabbits on 0.5% cholesterol diet. Whole images of arterial sections of normal artery (a) or atherosclerotic
artery (b) 15 minutes after balloon injury. The size of thrombus signiﬁcantly diﬀers between normal artery thrombus and atherothrombus
(∗). The normal artery thrombus is too small to recognize. Hematoxylin eosin stain. Rows (c, d) show diﬀerential interference contrast,
ﬂuorescein isothiocyanate-labeled GPIIb/IIIa (green), Cy3-labeled ﬁbrin (red), and merged immunoﬂuorescent images. Areas with
colocalized factors are stained yellow. Thrombi on normal intima are composed of small aggregated platelets (c), whereas those on
atherosclerotic neointima comprise platelets and ﬁbrin (d). I, intima; M, media; IEL, internal elastic lamina (from Yamashita et al. [28]
with permission).
denudation, whereas thrombin-independent small platelet
thrombiwereinducedinnormalfemoralarteriesdamagedin
the same manner (Figure 5)[ 27, 28]. Moreover, whole blood
coagulation in the rabbit model of atherothrombosis was not
aﬀected by inhibiting blood TF using a TF antibody even
underhyperlipidemicconditions[28].Therefore,atheroscle-
rotic plaque-derived TF might contribute to activation of the
intravascular coagulation cascade and thrombus growth on
atherosclerotic lesions.
Recentstudiesinvitroindicatethat,inadditiontomono-
cytes, various types of blood cells including neutrophils,
eosinophils, and even platelets can synthesize TF. Although
TF expression in these blood cells is a matter of debate,
monocytes are probably the only blood cells that synthesize
and express TF [53]. A related topic is the contribution of
microparticles(MPs)tothrombusformation.Microparticles
are small fragments of membrane-bound cytoplasm that are
shed from the surface of activated or apoptotic cells [54].
The procoagulant activity of MPs increases with exposure
to phosphatidylserine and TF. Clinical studies have found
signiﬁcantly elevated amounts of MPs in patients with acute
coronary syndrome and ischemic stroke [55, 56]. However,10 Journal of Biomedicine and Biotechnology
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Figure 6: Representative longitudinal microphotographs of rabbit femoral artery with smooth muscle cell-rich neointima 15 minutes
after vascular narrowing. (a) Broad superﬁcial neointimal damage at poststenotic region. Neointimal cell detachment (small arrows) at
high magniﬁcation. N, neointima; M, media; Ad, adventitia. Large arrow indicates blood ﬂow. (b) Immunohistochemistry to detect von
Willebrand factor (VWF, endothelial marker) and smooth muscle actin (SMA, smooth muscle marker) conﬁrms detachment of endothelial
and smooth muscle cells at poststenotic region. HE (hematoxylin eosin stain) (from Sumi et al. [45]).Journal of Biomedicine and Biotechnology 11
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Figure 7:Muralthrombusgrowthonneointimaafterbloodﬂowreduction.Smallthrombi(arrows)areinducedbyballooninjuryofnormal
femoral artery without (a) or with blood ﬂow reduction to 50% (b) or 25% (c). Transmission electron micrograph (d) shows that thrombi
consist of aggregated platelets (IEL, internal elastic lamina). Platelet ﬁbrin-rich mural thrombi (arrow heads) are induced by balloon injury
of neointima without (e) or with blood ﬂow reduction to 50% (f). Neointimal injury with blood ﬂow reduction to 25% causes occlusive
thrombus formation (g). Transmission electron micrograph (h) shows that these thrombi are composed of abundant ﬁbrin strands (f)
admixed with platelets (p). Hematoxylin eosin/Victria blue stain (a-c, e-g). (from Yamashita et al. [27] with permission).
whether elevated levels of MPs are a cause or a consequence
of atherothrombosis remains unclear. Further studies are
required to clarify the contribution of blood-derived TF
and/or MPs to thrombus growth on atherosclerotic lesions.
Another mechanism that might contribute to thrombus
growth in vivo is the intrinsic coagulation pathway that
is initiated when coagulation factor XII (FXII) comes into
contact with negatively charged surfaces. Factor XI (XI) is
activated by activated FXII, thrombin, and activated XI.
Feedback activation of FXI by thrombin promotes further
thrombin generation in vitro [57]. Factor XI is present in
platelet-ﬁbrinthrombus-inducedballooninjuryoftherabbit
atherosclerotic neointima, and anti-FXI antibody reduces
thrombus growth without prolonging bleeding time [58].
This evidence indicates that intrinsic coagulation factors
play a more signiﬁcant role in thrombus growth than initial
thrombus formation.
6.2. Role of Blood Flow on Thrombus Growth. Blood ﬂow is
a key modulator of thrombus growth. Some clinical studies
have shown that blood ﬂow is altered during coronary
atherothrombosis. Marzilli et al. [59] identiﬁed an approxi-
mate 80% reduction in coronary blood ﬂow during ischemia
in patients with unstable angina. Hearts obtained from
patientsaftersuddencoronarydeathcontainedameanof4.5
intramyocardial microemboli, which are more common in
plaque erosion than rupture and are associated with myocar-
d i a ln e c r o s i s[ 60]. These mechanisms are considered to be
largely responsible for the rapid elevation of distal vascular
resistance due to microvascular embolism and/or vasocon-
striction [61]. To assess how blood ﬂow aﬀects thrombus
growth on atherosclerotic lesions, we reduced blood ﬂow in
rabbit femoral arteries after thrombus formation. Platelet-
ﬁbrin mural thrombi on atherosclerotic neointima became
occlusive in the setting of >7 5 %r e d u c t i o ni nb l o o dﬂ o w .I n
contrast, small platelet thrombi on normal arteries did not
grow even under a 90% reduction in blood ﬂow (Figure 7)
[27]. Thus, reduced blood ﬂow during thrombus formation
might aﬀect only the formation of occlusive thrombus in
atherosclerotic vessels.
In addition to distal vascular resistance, blood ﬂow
disturbed by acute vascular narrowing promotes throm-
bus growth at poststenotic regions. As described above,
vascular narrowing of the rabbit femoral artery caused a
superﬁcial erosive injury at poststenotic regions of SMC-
rich neointima. Intimal damage signiﬁcantly progressed
at 3h after vascular narrowing. Thrombi that developed
on the neointima consisted of a mixture of aggregated
platelets and a considerable amount of ﬁbrin. In contrast,
the identical vascular narrowing of normal femoral arteries
also induced endothelial detachment with small platelet
thrombi at poststenotic regions. Neither vascular narrowing
nor antirabbit TF antibody aﬀected whole blood hemostatic
parameters in the rabbits, and no ﬁbrin was generated
in thrombi on eroded normal intima [45]. This evidence
indicates that TF derived from eroded neointima plays a12 Journal of Biomedicine and Biotechnology
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Figure 8: Schema of atherothrombus growth. Atherothrombus formation is initiated by plaque disruption and exposure of matrix proteins
andtissuefactor(TF).Thisinducesinitialplatelet(Plt)adhesion/aggregationandactivationofcoagulationcascade.Thrombin(IIa)activates
factor XI, factor VIII, and factor V on activated platelets, which amplify thrombin generation. Excess thrombin generation enhances ﬁbrin
formation and platelet aggregation on atherosclerotic plaque. The thrombin-dependent thrombus formation is mediated by plaque TF.
Disturbed blood ﬂow also promotes coagulation cascade and platelet recruitment by von Willebrand factor (VWF). The platelet recruitment
is negatively regulated by ADAMTS-13 (a disintegrin and a metalloprotease with a thrombospondin type 1 motif 13).
crucial role in ﬁbrin formation and thrombus growth rather
than circulating TF. Therefore, ﬂow that becomes disor-
dered after plaque disruption might contribute to thrombus
growth under conditions of distal resistance and of proximal
stenosis.
The rheological eﬀect on thrombus growth might be
partly explained by a shear gradient-dependent platelet
aggregation mechanism. Nesbitt et al. [62] showed using
imaging modalities that a shear gradient-dependent
platelet aggregation process is preceded by soluble agonist-
dependent aggregation stenotic microvessels in vitro and
in vivo. A shear microgradient at poststenotic regions or
at the downstream face of thrombi induces stable discoid
platelet aggregates with restricted tethers, and the magnitude
and spatial distribution of shear microgradients directly
inﬂuence the size of platelet aggregates. This process
required ligand binding to integrin αIIbβ3 and an inositol
triphosphate- and extracellular Ca2+-dependent transient
Ca2+ ﬂux, but not global platelet shape change, degranula-
tion,orsolubleagonists.Stabilizeddiscoidplateletaggregates
consolidated within the thrombus base and depended on
soluble agonists. These ﬁndings suggest that platelets prin-
cipally use a biomechanical platelet aggregation mechanism
to promote the accumulation and stabilization of discoid
platelets at sites of vascular injury. Vessel and/or thrombus
geometry itself might promote thrombus formation.
6.3. Role of Platelet Recruitment on Thrombus Growth.
Adhesion molecules and their receptors on platelets are
essential for thrombus formation. The large, multimeric
plasma protein VWF undergoes a conformational change
when bound to a matrix, a process that allows VWF to
bind GPIbα. Recent experimental evidence in vitro and in
vivo has shown that platelet recruitment on the thrombus
surfaceisprimarilymediatedbyVWFandGPIbα on ﬂowing
platelets [63, 64]. Despite limited understanding of the roles
of VWF on atherothrombus, its presence in human coronary
thrombi suggests that it exerts an important function in this
process [5, 6]. A monoclonal antibody against the VWF A1
domain, which interacts with platelet GPIbα signiﬁcantly
inhibited the formation of ﬁbrin-rich mural thrombus
induced by balloon injury of the rabbit atherosclerotic
neointima [65]. The antibody also completely inhibited
occlusive thrombus formation on rabbit atherosclerotic
vessels even when blood ﬂow was disturbed [27]. Thus,
VWF plays an important role in thrombus propagation on
atherosclerotic lesions via platelet recruitment.
T h es i z eo ft h eV W Fm u l t i m e rc a na ﬀect that of
thrombus, and the size of the VWF multimer is regulated
by a plasma protease, a disintegrin, and a metalloprotease
with a thrombospondin type 1 motif 13 (ADAMTS-13). A
deﬁciency in ADAMTS-13 activity leads to an increased level
of circulating ultralarge VWF multimers, and this correlates
with the onset of general thrombotic thrombocytopenic
purpura (TTP). Clinical evidence suggests that the size of
the VWF multimer is dysregulated in patients with AMI. The
ratio of VWF/ADAMTS-13 antigen is higher in patients with
AMI than with stable angina pectoris, and the correlation
between plasma VWF antigen and ADAMTS-13 activity
is inverse in patients with AMI [66]. ADAMTS-13 closely
localizes with VWF in fresh coronary thrombi from AMI
patients [67]. Reducing ADAMTS-13 activity using a mono-
clonalantibodyagainstthedisintegrin-likedomainenhances
platelet thrombus growth on immobilized type I collagen at
a high shear rate and platelet-ﬁbrin thrombus formation on
the injured neointima of rabbit femoral arteries [67]. This
studyalsoshowedthatlargeVWFmultimersarecleaveddur-
ing platelet thrombus formation under a high shear rate. The
site of VWF cleavage by ADAMTS-13 is localized to the sur-
face of platelet thrombus, and ADAMTS-13 activity is shear
dependent [68]. Thus, ADAMTS-13 might function at sites
ofongoingthrombusgenerationandlimitthrombusgrowth.Journal of Biomedicine and Biotechnology 13
7. LimitationsandFutureDirections
The rabbit model of atherothrombosis has several limita-
tions. The histological features of unstable plaque include
a high lipid content, intensive macrophage accumulation, a
l a r g en e c r o t i cc o r ew i t hat h i nﬁ b r o u sc a p ,a n df e wS M C s .
Although a high-cholesterol diet combined with balloon
injury induces macrophage-rich lesions at damaged sites,
a large necrotic core with a thin ﬁbrous cap is diﬃcult
to develop. This limits assessments of the pathogenesis of
plaque rupture in this model. The thickness (∼500μm) of
diseased arterial walls interferes with intravital microscopic
visualizationofthrombusformationinvivo,andtherabbitis
at a distinct disadvantage compared with the mouse in terms
of genomic and protein information.
Despite these potential limitations, the model based on
human pathology will nevertheless provide valuable infor-
mation about the pathophysiology of atherothrombosis.
Larger size in rabbits will be more suitable than mice for
stent implantation as well as direct vascular or thrombus
imaging using magnetic resonance imaging and positron
emissiontomography[69,70].Accumulatinggenomicinfor-
mation about rabbits is already publicly available. Important
ﬁndings have been generated from studies of atherogenesis
and lipid metabolism in transgenic rabbits generated by
pronuclear microinjection [71]. Several embryonic stem
cell lines have major important features in common with
human embryonic stem cells [72, 73]. Stable pluripotent
stem cells have recently been generated from rabbit somatic
cells by the introduction of four human transcription factors
[74]. The molecular mechanisms of atherothrombosis will
soon be uncovered via the rapid accumulation of molecular
information and progress in stem cell technology.
8. Conclusions
Procoagulant activity is increased by active TF expression in
human atherosclerotic lesions, and occlusive atherothrom-
bus consistently comprises aggregated platelets, ﬁbrin, and
erythrocytes. Balloon injury of the neointima expressing TF
induces large plate-ﬁbrin thrombi in diseased arteries of
a rabbit model. Enhanced platelet aggregation and ﬁbrin
formation in atherosclerotic arteries is primarily mediated
by neointimal TF in this model. Studies using this model
have revealed thrombin-dependent thrombus formation in
atherosclerotic vessels, plaque erosion induced by disturbed
blood ﬂow, thrombogenic vasoconstriction of SMC-rich
neointima, and the factors involved in thrombus growth
(Figure 8). Overcoming the limitations of the rabbit model
using emerging transgenic and stem cell technologies might
lead to its establishment as an invaluable experimental tool
for understanding the mechanisms of atherosclerosis.
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